GSK•benzinga•
GSK, Pfizer's ViiV Healthcare Shows Strong HIV Viral Suppression In Latest Study
Summary
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early data on VH184 and VH499 therapies.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 12, 2025 by benzinga